Citadel Advisors »

Apellis Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $65M 1.1M 59.86
2023-09-30 $38M 1.0M 38.04
2023-06-30 $80M 875k 91.10
2023-03-31 $38M 580k 65.96
2022-12-31 $25M 490k 51.71
2022-06-30 $20M 444k 45.22
2022-03-31 $36M 714k 50.81
2021-12-31 $59M 1.3M 47.28
2021-09-30 $92M 2.8M 32.96
2021-06-30 $34M 540k 63.20
2021-03-31 $6.2M 146k 42.91
2020-12-31 $86M 1.5M 57.21
2020-09-30 $68M 2.2M 30.17
2020-06-30 $47M 1.4M 32.66
2020-03-31 $23M 871k 26.79
2019-12-31 $20M 636k 30.62
2019-06-30 $16M 642k 25.34
2019-03-31 $18M 945k 19.50
2018-12-31 $664k 50k 13.20
2018-09-30 $1.1M 64k 17.62
2018-06-30 $247k 11k 21.95